Mechanistic Insights of Empagliflozin-Mediated Cardiac Benefits: Nearing the Starting Line: Editorial to: “Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes” by N. Hammoudi et al.

Academic Article

Authors

Published In

Digital Object Identifier (doi)

Author List

  • Gupte M; Umbarkar P; Lal H
  • Start Page

  • 229
  • End Page

  • 232
  • Volume

  • 31
  • Issue

  • 3